87 related articles for article (PubMed ID: 9396075)
1. Effects of acute and chronic administration of L-arginine on the antinociceptive action of morphine-6-beta-D-glucuronide.
Bhargava HN; Bian JT
Pharmacology; 1997 Oct; 55(4):165-72. PubMed ID: 9396075
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic administration of L-arginine, NG-nitro-L-arginine or their combination on morphine concentration in peripheral tissues and urine of the mouse.
Bian JT; Bhargava HN
Gen Pharmacol; 1998 May; 30(5):753-7. PubMed ID: 9559330
[TBL] [Abstract][Full Text] [Related]
3. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
4. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
Faura CC; Olaso JM; Cabanes CG; Horga JF
Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test.
Lötsch J; Tegeder I; Angst MS; Geisslinger G
Life Sci; 2000 May; 66(24):2393-403. PubMed ID: 10864101
[TBL] [Abstract][Full Text] [Related]
6. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
[TBL] [Abstract][Full Text] [Related]
7. Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice.
Romberg R; Sarton E; Teppema L; Matthes HW; Kieffer BL; Dahan A
Br J Anaesth; 2003 Dec; 91(6):862-70. PubMed ID: 14633759
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine.
Bhargava HN; Bian JT; Kumar S
J Pharmacol Exp Ther; 1997 May; 281(2):707-12. PubMed ID: 9152376
[TBL] [Abstract][Full Text] [Related]
9. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
[TBL] [Abstract][Full Text] [Related]
10. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.
Qian-Ling G; Hedner J; Björkman R; Hedner T
Pain; 1992 Feb; 48(2):249-255. PubMed ID: 1589243
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
Easterling KW; Holtzman SG
Psychopharmacology (Berl); 1998 Nov; 140(1):91-7. PubMed ID: 9862407
[TBL] [Abstract][Full Text] [Related]
12. N(G)-nitro-L-arginine reverses L-arginine induced changes in morphine antinociception and distribution of morphine in brain regions and spinal cord of the mouse.
Bhargava HN; Bian JT
Brain Res; 1997 Feb; 749(2):351-3. PubMed ID: 9138738
[TBL] [Abstract][Full Text] [Related]
13. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance.
Xu JY; Hill KP; Bidlack JM
J Pharmacol Exp Ther; 1998 Jan; 284(1):196-201. PubMed ID: 9435178
[TBL] [Abstract][Full Text] [Related]
14. Influence of opiate tolerance and calcium channel antagonists on the antinociceptive effects of L-arginine and NG-nitro L-arginine.
Contreras E; Germany A; Gonzalez P; Norris B
Gen Pharmacol; 1997 Mar; 28(3):443-8. PubMed ID: 9068988
[TBL] [Abstract][Full Text] [Related]
15. Chronic running wheel activity attenuates the antinociceptive actions of morphine and morphine-6-glucouronide administration into the periaqueductal gray in rats.
Mathes WF; Kanarek RB
Pharmacol Biochem Behav; 2006 Apr; 83(4):578-84. PubMed ID: 16712909
[TBL] [Abstract][Full Text] [Related]
16. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
[TBL] [Abstract][Full Text] [Related]
17. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats.
South SM; Smith MT
J Pharmacol Exp Ther; 1998 Sep; 286(3):1326-32. PubMed ID: 9732396
[TBL] [Abstract][Full Text] [Related]
18. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
Francés B; Gout R; Campistron G; Panconi E; Cros J
Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
[TBL] [Abstract][Full Text] [Related]
19. Wheel running attenuates the antinociceptive properties of morphine and its metabolite, morphine-6-glucuronide, in rats.
Mathes WF; Kanarek RB
Physiol Behav; 2001 Sep 1-15; 74(1-2):245-51. PubMed ID: 11564474
[TBL] [Abstract][Full Text] [Related]
20. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
